Injeq

📍 Tampere, Finland👥 22 employees💰 Last funded Jul 2019
Medical Equipment Manufacturing🌐 injeq.com
Website LinkedIn
Injeq is developing intelligent medical technology - smart needles - for demanding lumbar punctures and medical injections. The leading product under development is the IQ-Tip® system, which is a novel method for demanding lumbar punctures. The clinical performance and safety of Injeq IQ-Tip® system have already been evaluated in three clinical investigations in university hospitals. The smart needle system is feasible for lumbar punctures from neonates to older adults, including treatment punctures of children with leukemia. Injeq IQ-Tip® products are designed and manufactured to meet the requirements of the new European Medical Device Regulation (MDR 2017/745). European market entry is expected soon. Injeq Quality Management System is certified according to the EN ISO 13485:2016.
3
Total investors
1
Early stage
0
Mid stage
3
Late stage
—
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Finland
4
Investor activity2012–2019 · investors recorded per year
201212017120192
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Injeq?
Injeq has 3 investors on record on gritt.io, including 1 early-stage backers and 3 late-stage investors.
When did Injeq last raise funding?
The most recent investment in Injeq recorded on gritt.io was in July 2019.
What industry is Injeq in?
Injeq operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Injeq based?
Injeq is headquartered in Tampere, Finland.